CALC · CalciMedica, Inc.
$0.46
-0.01 (-1.19%)
At close · Aug 28
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plans, we believe our cash and cash equivalents will be sufficient to fund our current operations into the second half of 2027. As a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$15.86M
Shares
6.83M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-06 | 79 | $0.74 | $58 |
| 2026-08-05 | 242 | $0.80 | $194 |
| 2026-08-04 | 88,805 | $0.74 | $65,716 |
| 2026-08-03 | 33,298 | $1.00 | $33,298 |
| 2026-07-31 | 1,055 | $0.84 | $886 |
| 2026-07-30 | 939 | $0.74 | $695 |
| 2026-07-28 | 72,137 | $0.70 | $50,496 |
| 2026-07-22 | 105,046 | $0.71 | $74,583 |
| 2026-07-21 | 96,431 | $0.70 | $67,502 |
| 2026-07-20 | 115,990 | $0.74 | $85,833 |
| 2026-07-17 | 156,842 | $0.69 | $108,221 |
| 2026-07-16 | 15,706 | $0.78 | $12,251 |
| 2026-07-15 | 12,208 | $0.74 | $9,034 |
| 2026-07-14 | 33,601 | $0.82 | $27,553 |
| 2026-07-09 | 4,416 | $0.90 | $3,974 |
| 2026-07-08 | 5 | $0.96 | $5 |
| 2026-07-07 | 5 | $0.99 | $5 |
| 2026-07-06 | 14,182 | $0.97 | $13,757 |
| 2026-07-02 | 35,925 | $1.04 | $37,362 |
| 2026-07-01 | 40,825 | $1.03 | $42,050 |
| 2026-06-30 | 242,463 | $0.99 | $240,038 |
| 2026-06-29 | 547,434 | $0.82 | $448,896 |
| 2026-06-26 | 1,157,745 | $0.63 | $729,379 |
| 2026-06-25 | 2,080,623 | $0.60 | $1,248,374 |
| 2026-06-24 | 10,700 | $0.80 | $8,560 |
| 2026-06-15 | 5,036 | $0.87 | $4,381 |
| 2026-06-12 | 63 | $0.89 | $56 |
| 2026-06-11 | 4,491 | $0.93 | $4,177 |
| 2026-06-09 | 24,915 | $0.96 | $23,918 |
Showing 1–29 of 29 settlements
Key facts
CIK
1534133
CUSIP
38942Q202
13F (30d)
35 filings
33 filers
Visit website
Investor relations